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Abstract
 
Thymic dendritic cells (DCs) form a discrete subset of bone marrow (BM)-derived cells, the
function of which is to mediate negative selection of autoreactive thymocytes. The develop-
mental origin of thymic DCs remains controversial. Although cell transfer studies support a
model in which T cells and thymic DCs develop from the same intrathymic pluripotential pre-
cursor, it remains possible that these two types of cells develop from independent intrathymic
precursors. Notch proteins are cell surface receptors involved in the regulation of cell fate spec-
ification. We have recently reported that T cell development in inducible Notch1-deficient
mice is severely impaired at an early stage, before the expression of T cell lineage markers. To
investigate whether development of thymic DCs also depends on Notch1, we have con-
structed mixed BM chimeric mice. We report here that thymic DC development from
 
Notch1
 
2
 
/
 
2
 
 BM precursors is absolutely normal (in terms of absolute number and phenotype)
in this competitive situation, despite the absence of Notch1
 
2
 
/
 
2
 
 T cells. Furthermore, we find
that peripheral DCs and Langerhans cells are also not affected by Notch1 deficiency. Our re-
sults demonstrate that the development of DCs is totally independent of Notch1 function, and
strongly suggest a dissociation between intrathymic T cell and DC precursors.
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Introduction
 
Dendritic cells (DCs)
 
1
 
 play a key role in T cell immune re-
sponses by endocytosing, processing, and presenting for-
eign antigens to specific T cells (1, 2). All DCs originate
from bone marrow (BM) precursors, but it is not clear
whether these precursors differentiate and mature to DCs
in the BM itself, or whether they migrate to and differenti-
ate within other organs.
Different lines of evidence point to the existence of two
types of DCs in the mouse. Although all DCs express
CD11c and MHC class II, the two subsets can be distin-
guished according to their differential expression of cell
 
surface markers such as CD8
 
a
 
, Mac-1, and DEC-205. The
CD8
 
a
 
1
 
Mac-1
 
2
 
DEC-205
 
1
 
 subset of DCs is thought to be
of lymphoid origin, whereas the CD8
 
a
 
2
 
Mac-1
 
1
 
DEC-
205
 
2
 
 DCs are believed to be myeloid derived. In the
spleen, where the function of DCs is to present foreign an-
tigens to specific T cells, both subpopulations of DCs are
present. However, thymic DCs whose function is to medi-
ate negative selection of autoreactive thymocytes (3) con-
stitute only the lymphoid-related subset (4–6).
The development of thymic DCs and T cells has been
reported to be closely linked via an intrathymic common
precursor (6, 7). In support of this hypothesis, intrathymic
 
transfer of either early T cell precursors (CD4
 
lo
 
CD44
 
1
 
CD25
 
2
 
CD117
 
1
 
) or progenitor T cells (CD4
 
2
 
CD44
 
1
 
CD25
 
1
 
CD117
 
1
 
) into sublethally irradiated mice results in
the production of both thymic DCs and mature T cells.
However, the next downstream population (defined as
CD4
 
2
 
, CD44
 
2
 
CD25
 
1
 
, CD117
 
2
 
) has lost DC potential
and generates only T cells (8). These data are consistent
with a lymphoid-related origin for thymic DCs, and sup-
 
port the existence of a common intrathymic T/DC pre-
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cursor (7, 8). Nevertheless, this hypothesis has not been
proven at the clonal level, and it remains possible that the
populations transferred contain distinct DC and T cell pre-
cursors that cannot be distinguished phenotypically.
Further evidence that DC and T cell development might
be closely linked is derived from gene-targeted mice. Mice
homozygous for an Ikaros dominant-negative mutation
(deletion of the DNA-binding domain) lack all cells of
lymphoid origin, such as T, B, and NK cells, as well as
lymphoid- and myeloid-derived DCs (9). More interest-
ingly, mice homozygous for an Ikaros null allele (deletion
of the COOH terminus of Ikaros) lack B and NK cells, as
well as lymph nodes, but maintain a certain T cell differen-
tiation potential (10). Although no myeloid DCs were
found in such mice, lymphoid-related DCs were present in
the thymus, suggesting a correlation between T cell and
thymic DC development (11).
Notch gene family members have been shown to play
crucial roles in binary cell fate decisions in many develop-
mental systems (12). Notch proteins are conserved trans-
membrane receptors containing EGF repeats in their
ectodomain that are implicated in ligand binding. The cy-
toplasmic domain harbors six ankyrin repeats and is in-
volved in intracellular signaling (13). To date, four mam-
malian Notch homologues (Notch1–4) that interact with
transmembrane-bound ligands such as Jagged1, Jagged2,
Delta1, and Delta-like3 have been identified (14–24).
Several reports suggest a role for Notch family members
in T cell development. Notch1, 2, and 3 as well as the
ligands Jagged1 and 2 have been shown to be expressed in
thymocytes and thymic stromal epithelium (25–27). Ex-
pression of transdominant active forms of Notch genes in
transgenic mice has implicated Notch signaling in T cell
development at the level of both CD4 versus CD8 and 
 
a
 
/
 
b
 
versus 
 
g
 
/
 
d
 
 cell fate decisions (28, 29). Notch signaling may
also regulate proliferation, survival, and/or apoptosis of de-
veloping T cells (30, 31).
We recently reported the generation of mice in which
the Notch1 gene was conditionally inactivated. Lethally ir-
radiated recipients reconstituted with BM cells derived
from induced Notch1
 
2
 
/
 
2
 
 mice were devoid of T cells in
both the thymus and periphery. Instead of T cells, imma-
ture B cells accumulated in the thymus of such BM chime-
ras, suggesting a possible role for Notch1 in regulating the
T versus B lineage decision (32). In other studies, transfer
of retrovirally infected BM-derived hematopoietic precur-
sor cells expressing the cytoplasmic domain of Notch1 has
recently been shown to impair early B cell development
and promote ectopic T cell development in the BM (33).
Taken together, these complementary reports support a
role for Notch1 in regulating T versus B cell fate specifica-
tion from a bipotent common lymphoid progenitor (CLP).
The putative ability of Notch1 to regulate the B/T lin-
eage decision in a binary fashion is of considerable interest
in relation to the developmental origin of thymic DCs. It is
generally accepted that progenitor B cells differentiate from
a CLP in the BM, whereas CLPs that reach the thymus can
adopt a T cell fate under the influence of the thymic mi-
 
croenvironment (34). Since thymic DCs are believed to be
derived from an intrathymic common T/DC precursor
that is downstream of the T/B lineage choice (7, 35), it is
of obvious interest to investigate whether thymic DCs can
arise from Notch1-deficient BM precursors.
Here, we show that although induced Notch1
 
2
 
/
 
2
 
 he-
matopoietic precursors are unable to generate T cells, they
retain their full potential to generate all other myeloid and
lymphoid lineages, including thymic DCs.
 
Materials and Methods
 
Generation of Mice with a loxP-flanked Notch1 Allele, and Activa-
tion of the Cre Recombinase.
 
Notch1
 
lox/lox
 
 and Notch1
 
lox/lox
 
 Mx-
Cre mice were generated as described previously (32). These
mice are positive for the common leukocyte antigen CD45.2.
Activation of the Cre recombinase was performed as described
previously (32). In brief, adult mice received five intraperitoneal
injections
 
 
 
of 250
 
 
 
m
 
g polyI-polyC (Sigma Chemical Co.) at 2-d
intervals. 2 d after the last injection, mice were killed, and the
BM was prepared for BM transplantation by T cell depletion.
Genomic DNA was prepared from a portion of the T cell–
depleted BM cells for assessing Notch1 deletion efficiency by
Southern blot, and was quantified using a PhosphorImager
 
®
 
(Molecular Dynamics).
 
Generation of Mixed BM Chimeras.
 
Mixed chimeras were
generated using a 1:2 mixture (10 
 
3 
 
10
 
6
 
 and 20 
 
3 
 
10
 
6
 
) of T cell–
depleted BM cells from polyI-polyC–treated CD45.1
 
1
 
 wild-type
(wt) and CD45.2
 
1
 
 Notch1
 
lox/lox
 
 or induced Notch1
 
2
 
/
 
2
 
 mice. 10-
wk-old hosts (C57BL/6, CD45.1
 
1
 
; purchased from The Jackson
Laboratory) were given 1,000 rads 
 
g
 
-irradiation 24 h before re-
ceiving the BM transplant. Radiation chimeras were maintained
on antibiotic water and analyzed after 3 mo.
 
Flow Cytometry and Antibodies.
 
Four-color FACS
 
®
 
 staining
was performed as described elsewhere (36) using the following
mAbs: anti-CD45.1–FITC or –biotin, anti-CD45.2–FITC or
–biotin, anti-CD11c–FITC or –PE, anti-CD3
 
e
 
–FITC or –allophy-
cocyanin (APC), anti-Gr1–APC, anti-CD11b–PE, anti-CD44–
CyChrome, anti-CD8
 
a
 
–CyChrome or –APC, anti-CD4–
CyChrome, anti-B220–CyChrome or –APC, and anti-NK1.1–PE
(PharMingen). Anti-F4/80–biotin was purified and conjugated in
this laboratory. Biotinylated antibodies were revealed with either
Streptavidin–CyChrome (PharMingen) or Streptavidin–APC
(Molecular Probes). All FACS
 
®
 
 analysis was performed using
four colors on a FACSCalibur™ flow cytometer (Becton Dickin-
son), and was analyzed using CELLQuest™ software (Becton
Dickinson). Dead cells were excluded by live gating of forward
scatter and side scatter, and 100,000–200,000 cells were analyzed
in each file.
 
Isolation of DCs from the Thymus and Spleen.
 
DC-enriched
cell suspensions were prepared as described previously (37). In
brief, organs were cut into small pieces and digested with collage-
nase A (0.5 mg/ml Boehringer Mannheim) and DNase I (40 
 
m
 
g/
ml; Boehringer Mannheim) in RPMI 1640 medium supple-
mented with 5% FCS for 10 min at 37
 
8
 
C with continuous agita-
tion. Digested fragments were filtered through a sieve, and the
cell suspension was washed twice in PBS supplemented with 5%
FCS and 5 mmol/liter EDTA containing 5 
 
m
 
g/ml DNase I. The
cells were then resuspended in cold isoosmotic Optiprep™ solu-
tion (Nyegaard Diagnostics), pH 7.2, 
 
d
 
 1.061 g/cm
 
3
 
, containing
5 mmol/liter EDTA to dissociate DC–thymocyte complexes, and
the low density fraction was obtained by centrifugation at 1,700 
 
g 
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for 10 min. This low density fraction was washed twice in PBS-
EDTA-FCS. DCs were identified in the low density cell fraction
as MHC class II
 
1
 
CD11c
 
1
 
B220
 
2
 
F4/80
 
2
 
 cells.
 
Isolation of Langerhans Cells from the Skin.
 
Langerhans cell
(LC) preparation was performed as described previously (37, 38).
In brief, ears were rinsed with 70% ethanol, split using forceps
into dorsal and ventral halves, and incubated with 0.5% trypsin
(Sigma Chemical Co.) in PBS containing 5% FCS for 30 min at
37
 
8
 
C to allow the separation of the epidermal sheets from dermis.
Subsequently, epidermal sheets were cultured for 24 h in 24-well
tissue culture plates in the presence of 100 ng/ml GM-CSF (pro-
vided by Immunex Corp., Seattle, WA). LCs, together with ke-
ratinocytes, were released into the culture medium. Epidermal
cell suspensions were obtained by filtering the culture medium
and epidermal sheets through a sieve, and were washed in PBS
with 5% FCS. LCs cells were identified in the epidermal cell sus-
pension as MHC class II
 
1
 
 and CD11c
 
1
 
 cells.
 
Analysis of DCs and Other Hematopoietic Lineages in the Mixed
BM Chimeras.
 
Two groups of mixed BM chimeras were con-
structed, CD45.1
 
1
 
 wt/CD45.2
 
1
 
 Notch1
 
lox/lox
 
 (
 
n
 
 5 
 
8) and
CD45.1
 
1
 
 wt/CD45.2
 
1
 
 induced Notch1
 
2
 
/
 
2
 
 (
 
n
 
 5 
 
15). Cells bear-
ing DC markers were analyzed on DC-enriched preparations
from pooled thymi and spleens derived from the BM chimeras.
Analyses of other hematopoietic lineages such as granulocytes,
macrophages, B cells, and NK cells were performed on BM and
spleens from individual mice.
 
Results
 
Experimental Strategy.
 
As the block in thymocyte devel-
opment after induced inactivation of Notch1 is at a very
early stage (32), Notch1 may also be involved in thymic DC
differentiation, affecting a putative intrathymic common
T/DC precursor. Since the deletion efficiency of Notch1
(mediated by the IFN-
 
a
 
–inducible MxCre transgene) in the
thymus is only 
 
z
 
40%, but is close to 100% in the BM, we
decided to investigate this question using BM chimeras. To
this end, CD45.2
 
1
 
 Notch1
 
lox/lox
 
 MxCre
 
1
 
/
 
2
 
 (Notch1
 
2
 
/
 
2
 
),
CD45.2
 
1
 
 Notch1
 
lox/lox
 
 (control), and CD45.1
 
1
 
 wt mice
were treated with the IFN-
 
a
 
 inducer polyI-polyC five
 
times at 2-d intervals to delete an essential portion of the
Notch1 gene (Fig. 1 A). 2 d after the last injection, BM was
harvested and prepared for transfer. To assess the Notch1
deletion efficiency, genomic DNA was prepared from a
sample of induced Notch1
 
2
 
/
 
2
 
 or control BM and analyzed
by Southern blot. The deletion efficiency in Notch1
 
2
 
/
 
2
 
BM was close to 100%, as expected (Fig. 1 B). Lethally irra-
diated wt hosts (CD45.1
 
1
 
) were reconstituted with either
CD45.2
 
1
 
 Notch1
 
2
 
/
 
2 
 
BM or CD45.2
 
1
 
 control BM, each
mixed in a 2:1 ratio with CD45.1
 
1
 
 wt BM (hereafter de-
scribed as Notch1
 
2
 
/
 
2
 
 or control chimeras, respectively), and
analyzed 3 mo later for the different myeloid and lymphoid
lineages derived from each donor population.
 
Notch1
 
2
 
/
 
2 BM Precursors Fail to Generate Thymic or Periph-
eral T Cells. The distribution of the two allelic markers
CD45.1 and CD45.2, which denote the donor origin of the
cells, showed an equivalent contribution of leukocytes from
each donor population in the blood of both control and
Notch1-deleted chimeras (Fig. 2 A). In the control chime-
ras, B2201 (B) and CD31 (T) cells derived from both
CD45.11 and CD45.21 BM were present, as expected.
However, in the Notch1-deleted chimeras, although B2201
B cells were derived from both donor populations, .99%
of CD31 T cells were derived from the CD45.11 wt BM,
and ,0.3% from the CD45.21 Notch1-deficient BM (Fig.
2 A).
In the thymus of control chimeras, reconstitution was
similar to that observed in blood and other peripheral or-
gans, with an equal contribution from both CD45.11 and
CD45.21 BM donor populations. In contrast, in the
Notch1-deleted chimeric thymus, 98% of cells were derived
from CD45.11 wt BM (Fig. 2 B), in spite of the fact that
absolute thymocyte numbers were similar in both control
and Notch1-deleted chimeras (z90 3 106). Furthermore,
most of the residual CD45.21 cells of Notch12/2 donor or-
igin were CD42CD82B2201 B cells (Fig. 2 B), confirming
that Notch1-deficient precursors are unable to generate T
cells in a competitive situation (32).
Figure 1. Inducible targeting of the
Notch1 gene. (A) Schematic representation
of the murine Notch1 gene. The Notch1
protein contains a signal peptide, 36 EGF re-
peats followed by a cysteine-rich domain
(LN) in the extracellular domain, a trans-
membrane domain (TM), cytoplasmic
ankyrin repeats (Cdc10), and a PEST se-
quence. The genomic organization of the
Notch1 locus derived from control mice is
partially shown (1); the exon coding for the
leader peptide (filled square) is flanked by
two loxP sequences (gray triangles), fol-
lowed by the exon coding for the first EGF
repeat (gray box). After induction of the Cre
recombinase, the genomic portion harbor-
ing the exon coding for the leader peptide is deleted (2). Arrows indicate EcoRI fragments that differ in size between the genomic locus derived from con-
trol mice and the locus after deleting the loxP-flanked gene segment (induced Notch12/2). (B) Southern blot analysis of EcoRI-digested genomic DNA
derived from the BM used for setting up the mixed chimeric mice. The probe indicated in A reveals a 5.8-kb fragment for the allele derived from control
animals (1), whereas deletion of the flanked loxP segment gives rise to a 2.3-kb fragment (2). Deletion efficiency was calculated after PhosphorImager®
analysis to be .98%.1088 Developmental Dissociation of Thymic DCs and T Cells
Notch12/2 BM Precursors Have the Full Potential for Gen-
erating Thymic DCs. To determine whether induced
Notch12/2 BM precursors are able to generate thymic
DCs, the low density thymocyte fraction was prepared
from control and Notch12/2 chimeras, and was stained
with a combination of cell surface markers specific for
DCs. As expected, a characteristic thymic DC population
with the phenotype MHC class II1CD11c1CD8a1 de-
rived from both CD45.11 and CD45.21 BM origin was
detected in control chimeras (Fig. 3 A). Surprisingly, in
the competitive situation where T cells could not be gen-
erated, a phenotypically identical population of CD45.21
DCs of Notch12/2 donor origin was detected in addition
to the wt CD45.11 DCs (Fig. 3 A). Even the absolute
numbers of thymic DCs derived from CD45.21 control or
CD45.21 Notch12/2 BM were similar compared with
DCs derived from wt BM (Fig. 3 B). This result clearly
demonstrates that thymic DC development is Notch1 in-
dependent, and furthermore, strongly suggests a develop-
mental dissociation between thymic DC and T cell pre-
cursors.
Notch12/2 BM Precursors Are Capable of Generating Pe-
ripheral DCs and LCs. To investigate whether Notch1
deficiency could also affect the generation of myeloid-
derived DCs, we analyzed splenic DCs in the same chi-
meric mice. As shown in Fig. 4, both lymphoid-related
DCs (characterized by the expression of CD8a) and my-
eloid-related DCs (which are CD8a2) of both CD45.11
and CD45.21 origin were present in similar numbers in
the spleens of control and Notch12/2 BM chimeras. This
result indicates that Notch1 deficiency does not affect
the generation of either myeloid- or lymphoid-related
splenic DCs.
Skin DCs, known as LCs, are immature DCs that differ-
entiate into mature DCs after antigenic stimulation and
migrate to the T cell areas of the draining lymph nodes (1).
To investigate if the generation of LCs was affected by the
loss of Notch1, LCs were isolated from the epidermis of
Figure 2. Induced Notch12/2
BM is unable to generate T cells
in mixed BM chimeras. Two
groups of mixed chimeric mice
(wt control and wt induced
Notch12/2) were analyzed 3 mo
after reconstitution with a 1:2
mixture of wt (CD45.1) and
control (Notch1lox/lox, CD45.2)
or induced Notch12/2
(CD45.2) BM-derived cells.
Representative data are shown
from each group. (A) FACS®
profiles of PBLs stained with
anti-CD45.1, anti-CD45.2,
anti-CD3, and anti-B220 anti-
bodies. On the left is shown the
relative contribution of the
competing CD45.1 (R1) versus
CD45.2 (R2) BM-derived pop-
ulations. In the middle and on
the right are shown the distribu-
tion of CD31 and B2201 cells
within the gated CD45.11 and
CD45.21 cell populations. (B)
FACS® profiles of thymocytes
stained with anti-CD45.1, anti-
CD45.2, anti-CD44, and anti-
B220 antibodies. On the left is
shown the relative contribution
of the competing CD45.1 versus
CD45.2 BM-derived popula-
tions. Absolute cell numbers
(3106) for thymocyte subsets
gated by CD4 and CD8 expres-
sion into CD4 single positive
(SP; CD41CD82), CD8 single
positive (CD42CD81), double
positive (DP; CD41CD81), and
double negative (DN; CD42
CD82) are shown in the bar dia-
gram. The bars represent average values of pooled thymi derived from eight BM chimeras from each group. In the bar diagram, gray bars correspond to
wt (CD45.1), and stippled bars correspond to control (Notch1lox/lox, CD45.2) or induced Notch12/2 (CD45.2) derived cell populations. On the right is
shown the distribution of CD441 and B2201 in the double-negative (CD42CD82) compartment of mixed BM chimeras constructed with wt (CD45.1)
and induced Notch12/2 (CD45.2) BM cells.1089 Radtke et al.
mouse ears from both control and Notch12/2 chimeric
mice. As shown in Fig. 5, MHC class II–expressing LCs
derived from Notch12/2 BM were present to a similar ex-
tent as LCs derived from control BM. Therefore, develop-
ment of this form of immature DC likewise appears to be
unaffected by the absence of Notch1.
Notch1 Deficiency Does Not Influence Granulocyte, Mac-
rophage, NK Cell, or B Cell Development. To investigate
whether the absence of Notch1 affects other myeloid or
lymphoid lineages, control or Notch1-deficient chimeric
BM was analyzed for the presence of granulocytes, mac-
rophages, and immature B cells by staining for the expres-
sion of Gr1, Mac-1, or B220, together with the corre-
Figure 3. Induced Notch12/2 BM generates thymic DCs in mixed BM chimeras. (A) Mixed chimeric mice were analyzed 3 mo after reconstitution
with a 1:2 mixture of wt (CD45.1) and control (Notch1lox/lox, CD45.2) or induced Notch12/2 (CD45.2) BM-derived populations. Thymi of these chi-
meric mice were pooled, and the DC fraction was enriched as described in Materials and Methods. The DC-enriched fraction was stained using anti-
F4/80, anti-CD11c, anti–MHC class II, and anti-CD8a antibodies. The graph shows a FACS® analysis of CD11c versus MHC class II gated on F4/
802 cells, as well as histograms for the expression of CD8a gated on CD11c1MHC class II1 cells. (B) Absolute cell numbers of thymic DCs derived
from control and Notch12/2 chimeric mice. The bars represent average values per thymus of two independent experiments, and the triangles represent
the average number of DCs per thymus from pooled thymi. n 5 4 for wt (CD45.1) plus control (CD45.2), and n 5 8 and 7 for wt (CD45.1) plus
Notch12/2 (CD45.2) chimeras.
Figure 4. Induced Notch12/2 BM generates splenic DCs in mixed
BM chimeras. The BM chimeric mice described in Fig. 3 were also ana-
lyzed for splenic DC development. Spleens of chimeric mice were
pooled, and the DC fraction was enriched as described in Materials and
Methods. The DC-enriched fraction was stained using either anti-
CD45.1 or anti-CD45.2, together with anti-F4/80, anti-CD11c, and
anti-CD8a antibodies. The graph shows a FACS® analysis of CD11c ver-
sus CD8a gated on F4/802 cells for the two different groups of chimeric
mice. Absolute numbers of the myeloid-related (CD11c1CD8a2) and
lymphoid-related (CD11c1CD8a1) DCs per spleen are indicated next to
the quadrants.
Figure 5. The generation of LCs is Notch1 independent. The same
chimeric mice as described in the legend to Fig. 4 were analyzed for the
presence of LCs, which were prepared from epidermal sheets of mouse
ears as described in Materials and Methods. The cell populations were
stained for the expression of CD45.1, CD45.2, and MHC class II. Per-
centages of LCs are indicated in the upper right quadrant.1090 Developmental Dissociation of Thymic DCs and T Cells
sponding allelic markers CD45.1 and CD45.2. As shown
in Fig. 6 A, the staining patterns for Gr1, Mac-1, and
B220 were indistinguishable between CD45.21 BM cells
of control or Notch12/2 donor origin. Similar results were
obtained when the spleens of the chimeras were analyzed
for the presence of NK cells using the marker NK1.1 (Fig.
6 A). Importantly, calculation of absolute cell numbers in
individual chimeric mice did not reveal any significant dif-
ferences (Fig. 6 B), indicating that Notch1 is dispensable
for the development of granulocytes, macrophages, B cells,
and NK cells.
Discussion
The data presented in this report demonstrate that
Notch1 deficiency dissociates the development of T cells
from all other known myeloid and lymphoid lineages.
Thus, although T cell development from Notch12/2 pre-
cursors is arrested at a very early stage, the development of
B cells, NK cells, macrophages, granulocytes, and DCs (in-
cluding both thymic and splenic DCs, as well as LCs) is un-
affected by Notch1 deficiency, even in a situation of com-
petitive repopulation in mixed BM chimeras. Collectively,
these results reveal an obligatory and selective role of
Notch1 in T cell fate determination.
Implications for Myeloid Differentiation. The finding that
Notch1 is expressed on BM CD341 progenitors (39), to-
gether with the observation that Notch ligands are ex-
pressed on BM stromal cells, initially led to the suggestion
of a role for the Notch pathway in myeloid and/or ery-
throid differentiation (40, 41). Further evidence for Notch
function in myelopoiesis comes from studies using 32D
cells, which are progenitor cells that can differentiate into
granulocytes in the presence of a cytokine cocktail. Expres-
sion of a dominant active form of Notch or activation of
full-length Notch1 by Jagged1 (a ligand for the Notch re-
ceptors) was found to inhibit differentiation of 32D cells in
response to the cytokine cocktail (40, 42). Our data indicat-
ing that Notch1 is dispensable for the development of DCs,
granulocytes, and macrophages in vivo appear to conflict
with previous results suggesting that constitutive Notch1
activity perturbs myeloid differentiation (40, 43). This dis-
crepancy may be due either to the experimental protocol
used for studying myeloid differentiation, or simply to the
fact that we cannot exclude the possibility that redundant
signaling from other Notch gene family members may res-
cue the development of myeloid lineages. Nevertheless, our
results are in agreement with a recent report in which retro-
viral infection of BM cells with a dominant active form of
Notch1 did not affect myeloid differentiation, although it
had profound effects on lymphoid differentiation (33).
Implications for B/T Cell Fate Determination. Two inde-
pendent lines of evidence implicate Notch1 in a binary lin-
eage decision of a CLP to develop into a B cell or a T cell.
First, as shown here and elsewhere (32), Notch12/2 BM
precursors are unable to develop into T cells in the thymus
of lethally irradiated wt recipients. However, instead of T
cells, immature B cells of Notch12/2 origin (with a pheno-
type indistinguishable from those normally found in BM)
accumulate in the irradiated wt thymus. In reciprocal ex-
periments, Pui et al. (33) have shown that transferred BM
cells overexpressing the constitutively active Notch1 intra-
cellular domain do not develop into B cells in the BM of
lethally irradiated recipients. Instead, immature T cells
(mainly of the CD41CD81 phenotype) accumulate in the
BM of these chimeric mice.
Taken together, these complementary “loss-of-function”
and “gain-of-function” studies clearly indicate that varying
levels of Notch1 expression not only control the develop-
ment of T and B cells, but in addition are capable of pro-
moting ectopic development of either lineage at the ex-
pense of the other. By analogy with the role of Notch genes
in invertebrate systems (12), the simplest interpretation of
these data would be that Notch1 provides a critical signal
that determines a binary (T or B) cell fate decision by a
CLP. Since the absence of Notch1 blocks T cell develop-
ment and promotes ectopic B cell development, whereas
Notch1 overexpression promotes ectopic T cell develop-
ment at the expense of B cells, we would hypothesize that
B cell development from the CLP represents the default
pathway or primary cell fate that occurs in the absence of
Notch1 signaling. According to this scenario, T cell devel-
opment would be the secondary fate of a CLP, and would
require Notch1 signaling.
Implications for the Existence of a Common Intrathymic T/DC
Precursor. Two types of experiments have led to the
Figure 6. The development of granulocytes, macrophages, B cells, and
NK cells is Notch1 independent. (A) Chimeric BM was analyzed for the
presence of granulocytes, macrophages, and B cells by staining with mAbs
specific for Gr1, Mac-1, and B220. Chimeric spleens were analyzed for
the presence of NK cells by staining NK1.1 gated on CD32 cells. The
histograms show the expression pattern of these markers in the CD45.21
cells derived from either control (thin line) or induced Notch12/2 (bold
line) BM cells. (B) Absolute cell numbers (3106) for Mac-11, Gr11,
B2201, and NK1.11(CD32) cells in the CD45.21 fraction derived from
either control or induced Notch12/2 BM cells are calculated and shown
as bar diagrams. The bars represent average values, and the triangles repre-
sent values from individual mice (n 5 8 for both control and induced
Notch12/2 chimeric mice).1091 Radtke et al.
widely held hypothesis (Fig. 7 A) that thymic DCs are a
lymphoid lineage derived from a common intrathymic
precursor that also gives rise to T cells: (a) intrathymic
transfer of sorted populations of CD441CD4lo precursors
or CD441CD251 progenitor T cells gives rise to both
thymic DCs and T cells in sublethally irradiated recipients
(7, 8); and (b) the development of thymic DCs and T cells
could not be clearly dissociated in gene-targeted mice de-
ficient for either Ikaros or RelB transcription factors (10,
11, 44). However, both of these lines of evidence are ulti-
mately based on correlations, and it remains possible that
thymic DCs and T cells are derived from independent pre-
cursors that cannot be phenotypically distinguished.
The clear-cut dissociation of intrathymic T cell and
DC development in chimeric mice reconstituted with
Notch12/2 BM cells provides a serious challenge to the hy-
pothesis that thymic DCs represent a lymphoid lineage de-
rived from a common T/DC precursor. Indeed, as shown
here and elsewhere (32), T cell development from
Notch12/2 BM precursors is blocked at a very early stage
(before expression of CD25), and preliminary results sug-
gest that the few remaining CD441 intrathymic cells of
Notch12/2 origin do not express typical markers of CLPs
such as Sca-1 and CD117 (data not shown). Nevertheless,
thymic DC development is totally unaffected (in terms of
both phenotype and absolute cell numbers) by Notch1 de-
ficiency. Taken together with the evidence that Notch1
probably controls T/B fate specification in a binary fashion
(described above), the simplest interpretation of our data
would be to postulate that in the absence of Notch1 signal-
ing, CLPs are deviated to the B cell lineage either before or
shortly after their entry into the thymus. According to this
scenario (Fig. 7 B), Notch1–deficient thymic DCs could
not be derived from a CLP, and hence would presumably
originate from an independent thymic DC precursor popu-
lation that has yet to be precisely identified.
Although we favor the hypothesis that T cells and thy-
mic DCs are derived from distinct intrathymic precursors
that differ in their developmental dependence on Notch1,
other interpretations of our data cannot be excluded. For
example, it is possible that thymic DCs arising from
Notch12/2 precursors represent an aberrant developmental
pathway in which CLPs are redirected to the DC fate in
the absence of Notch1 signaling. According to this model,
differentiation into thymic DCs could be considered as an
alternative default pathway (or primary fate) of intrathymic
CLPs. Nevertheless, the fact that thymic DC development
from Notch12/2 precursors is not noticeably perturbed
(with respect to either phenotype or absolute cell numbers)
is difficult to reconcile with an altered T/DC cell fate spec-
ification, particularly when the effect of Notch1 deficiency
on the T/B lineage decision is so dramatic.
Finally, the possibility cannot be formally excluded that
other developmental pathways may lead to the production
of thymic DCs in normal mice. For instance, thymic DCs
may develop from a lymphoid precursor that is more
closely related to B cells than to T cells. Such a putative
B/DC precursor would presumably retain its bipotentiality
in the absence of Notch1. Alternatively, thymic DC devel-
opment may be a highly flexible process, with both lym-
phoid and nonlymphoid precursors having the potential to
give rise to DCs depending on the availability of microen-
vironmental cues.
In conclusion, our data demonstrate that Notch1 is dis-
pensable for the development of all myeloid and lymphoid
lineages with the exception of T cells. Moreover, taken to-
gether with a recent report by Rodewald et al. (45), they
seriously challenge the widely held hypothesis that thymic
DCs and T cells share a common intrathymic precursor.
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